Pediatric Allergic Rhinitis: When Meds Fall Short - Summary - MDSpire
From the Journals

Pediatric Allergic Rhinitis: When Meds Fall Short

Prospective cohort compares surgical vs medical management in refractory pediatric disease.

Share

Inferior turbinate reduction shows significant improvement in sinonasal symptoms and sleep-related quality of life in pediatric patients aged 5 to 17 with refractory allergic rhinitis after 1 and 3 months, compared to ongoing medical therapy. A study involving 34 patients revealed that those undergoing surgery exhibited greater decreases in symptom scores, complete disease regression, and reduced reliance on medications. However, the study noted limitations, including a small sample size and potential selection bias, as it was based on parental choice. Lead author Jad Hosri highlights these findings.

Original Source(s)

Pediatric Allergic Rhinitis: When Meds Fall Short

  • by Kathryn Wighton

  • April 9, 2026

Related Content

First and only center in Arizona to receive highest designation for advanced life support

Phoenix Children’s has been recognized with the prestigious ELSO Award for Excellence in Life Support, achieving Platinum Center of Excellence status from the Extracorporeal Life Support Organization (ELSO).

  • by

  • April 9, 2026

  • 4 min
Recognition and Management of Metabolic Epilepsies

This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathies

  • April 7, 2026

Rett Syndrome - a Multidisciplinary Approach

This presentation by Dr. Terry Grebe and Dr. Venode Narayanan outlines the multidisciplinary clinical management of Rett Syndrome (a neurodevelopmental disorder typically linked to MECP2 mutations) and explores emerging research, including the FDA-approved treatment trofinetide and experimental gene editing therapies.

  • April 7, 2026